We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+10.88%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$7.12B
AUM Growth
+$596M
Cap. Flow
+$91.3M
Cap. Flow %
1.28%
Top 10 Hldgs %
11.77%
Holding
645
New
72
Increased
209
Reduced
241
Closed
76

Top Sells

Rank Stock Value
1
REVG
REV Group
REVG
+$46.8M
2
UNH icon
UnitedHealth
UNH
+$43.8M
3
AZEK
The AZEK Co
AZEK
+$23.3M
4
MCK icon
McKesson
MCK
+$21.1M
5
TJX icon
TJX Companies
TJX
+$17.8M

Sector Composition

Rank Sector Weight
1 Technology 20.65%
2 Industrials 18.36%
3 Financials 15.32%
4 Healthcare 12.69%
5 Consumer Discretionary 11.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VITL icon
201
Vital Farms
VITL
$586M
$11.8M 0.17%
305,645
+153,065
+100% +$5.17M
PRCT icon
202
Procept Biorobotics
PRCT
$1.02B
$11.7M 0.16%
203,441
+34,559
+20% +$1.95M
STE icon
203
Steris
STE
$22.9B
$11.5M 0.16%
48,040
+3,352
+8% +$780K
CLH icon
204
Clean Harbors
CLH
$17.2B
$11.5M 0.16%
49,853
-7,359
-13% -$1.61M
KDP icon
205
Keurig Dr Pepper
KDP
$42.8B
$11.5M 0.16%
+348,303
New +$11.8M
BBWI icon
206
Bath & Body Works
BBWI
$3.97B
$11.3M 0.16%
378,264
+19,329
+5% +$566K
IDXX icon
207
Idexx Laboratories
IDXX
$44.9B
$11.3M 0.16%
21,086
+2,140
+11% +$1.02M
SU icon
208
Suncor Energy
SU
$77.7B
$11.3M 0.16%
301,201
-16,773
-5% -$607K
LASR icon
209
nLIGHT
LASR
$3.33B
$11.1M 0.16%
563,872
-643,708
-53% -$8M
WCN
210
Waste Connections
WCN
$43.6B
$11M 0.16%
59,104
+2,457
+4% +$473K
SITM icon
211
SiTime
SITM
$13.8B
$11M 0.15%
51,748
+8,816
+21% +$1.59M
OPCH icon
212
Option Care Health
OPCH
$3.76B
$11M 0.15%
338,960
+57,090
+20% +$1.84M
PPBI
213
DELISTED
Pacific Premier Bancorp
PPBI
$11M 0.15%
520,214
-17,743
-3% -$369K
BCRX icon
214
BioCryst Pharmaceuticals
BCRX
$2.42B
$10.9M 0.15%
1,220,077
-110,237
-8% -$1.03M
ITRI icon
215
Itron
ITRI
$4.54B
$10.9M 0.15%
83,000
+14,093
+20% +$1.59M
SLB icon
216
SLB Ltd
SLB
$72.7B
$10.9M 0.15%
323,084
-22,521
-7% -$781K
BFAM icon
217
Bright Horizons
BFAM
$4.35B
$10.9M 0.15%
87,934
+15,069
+21% +$1.85M
ZTS icon
218
Zoetis
ZTS
$32.7B
$10.7M 0.15%
68,513
+6,261
+10% +$993K
KAI icon
219
Kadant
KAI
$3.58B
$10.7M 0.15%
33,617
-307
-0.9% -$96.1K
RTX icon
220
RTX Corp
RTX
$290B
$10.6M 0.15%
72,830
-19,370
-21% -$2.58M
H icon
221
Hyatt Hotels
H
$17.5B
$10.6M 0.15%
+76,123
New +$9.5M
WAT icon
222
Waters Corp
WAT
$37.3B
$10.6M 0.15%
30,442
-3,933
-11% -$1.35M
CMG icon
223
Chipotle Mexican Grill
CMG
$43.9B
$10.4M 0.15%
185,575
-9,219
-5% -$469K
BCPC
224
Balchem Corp
BCPC
$5.26B
$10.3M 0.15%
64,907
+9,591
+17% +$1.56M
CHRD icon
225
Chord Energy
CHRD
$7.68B
$10.3M 0.14%
106,110
+6,155
+6% +$586K

Similar funds

Segall Bryant & Hamill's Q2 2025 Portfolio in Review

As of Q2 2025, Segall Bryant & Hamill held 645 positions worth $7.12B, up 9.1% from $6.53B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Segall Bryant & Hamill's Q2 2025 filing shows 72 new, 209 increased, 241 reduced and 76 closed positions. Its largest new stake was Flowserve: 345,600 shares worth $18.1M. The largest sale was REV Group, an estimated $46.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q2 2025 buy was Flowserve: 345,600 shares worth $18.1M.
  • Segall Bryant & Hamill added most to Meta Platforms (Facebook) in Q2 2025, an estimated $28.6M increase.
  • Segall Bryant & Hamill's biggest Q2 2025 reduction was REV Group, cutting an estimated $46.8M.
  • Segall Bryant & Hamill fully exited UnitedHealth in Q2 2025, selling an estimated $43.8M.
  • Segall Bryant & Hamill's ten largest holdings make up 12% of its $7.12B portfolio in Q2 2025.
  • Segall Bryant & Hamill opened 72 new positions and closed 76 in Q2 2025.
  • Segall Bryant & Hamill's portfolio value rose 9.1% quarter-over-quarter to $7.12B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2025, filed 12 Aug 2025.